Advances in the clinical management of uveal melanoma

RD Carvajal, JJ Sacco, MJ Jager… - Nature Reviews …, 2023 - nature.com
Melanomas arising in the uveal tract of the eye are a rare form of the disease with a biology
and clinical phenotype distinct from their more common cutaneous counterparts. Treatment …

Uveal melanoma: relatively rare but deadly cancer

S Kaliki, CL Shields - Eye, 2017 - nature.com
Although it is a relatively rare disease, primarily found in the Caucasian population, uveal
melanoma is the most common primary intraocular tumor in adults with a mean age …

[HTML][HTML] Metastatic uveal melanoma: The final frontier

ES Rantala, MM Hernberg, S Piperno-Neumann… - Progress in Retinal and …, 2022 - Elsevier
Abstract Treatment of primary intraocular uveal melanoma has developed considerably, its
driver genes are largely unraveled, and the ways to assess its risk for metastases are very …

Treatment of uveal melanoma: where are we now?

J Yang, DK Manson, BP Marr… - … advances in medical …, 2018 - journals.sagepub.com
Uveal melanoma, a rare subset of melanoma, is the most common primary intraocular
malignancy in adults. Despite effective primary therapy, nearly 50% of patients will develop …

Uveal melanoma: epidemiology, etiology, and treatment of primary disease

BA Krantz, N Dave, KM Komatsubara… - Clinical …, 2017 - Taylor & Francis
Uveal melanoma (UM) is the most common intraocular malignancy and arises from
melanocytes in the iris, ciliary body, or choroid. Early diagnosis and local treatment is …

Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis

ES Rantala, M Hernberg, TT Kivelä - Melanoma research, 2019 - journals.lww.com
The overall survival (OS) of patients with metastatic uveal melanoma is short, the evidence
for effectiveness of treatments is limited, and no consensus on the choice of treatment exists …

[HTML][HTML] Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) …

L Khoja, EG Atenafu, S Suciu, S Leyvraz, T Sato… - Annals of …, 2019 - Elsevier
Background Despite the completion of numerous phase II studies, a standard of care
treatment has yet to be defined for metastatic uveal melanoma (mUM). To determine …

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial

RD Carvajal, JA Sosman, JF Quevedo, MM Milhem… - Jama, 2014 - jamanetwork.com
Importance Uveal melanoma is characterized by mutations inGNAQandGNA11, resulting in
mitogen-activated protein kinase pathway activation. Objective To assess the efficacy of …

Uveal melanoma: estimating prognosis

S Kaliki, CL Shields, JA Shields - Indian journal of ophthalmology, 2015 - journals.lww.com
Uveal melanoma is the most common primary malignant tumor of the eye in adults,
predominantly found in Caucasians. Local tumor control of uveal melanoma is excellent, yet …

The biology of uveal melanoma

A Amaro, R Gangemi, F Piaggio, G Angelini… - Cancer and Metastasis …, 2017 - Springer
Uveal melanoma (UM), a rare cancer of the eye, is distinct from cutaneous melanoma by its
etiology, the mutation frequency and profile, and its clinical behavior including resistance to …